APIMEDS PHARMACEUTICALS US, INC. Cash and Restricted Cash
APIMEDS PHARMACEUTICALS US, INC. (APUS) had Cash and Restricted Cash of $8.28 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.28M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.98M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.64M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.99M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $8.28M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $8.98M 10-Q · filed 2026-05-26 | |
| 2025-12-31 | $9.64M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.99M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $8.74M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $250.43K 10-Q · filed 2026-05-26 | $250.34K 10-Q · filed 2025-05-20 |
| 2024-12-31 | $3.46K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $26.57K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $63.33K 10-Q · filed 2025-08-19 | |
| 2024-03-31 | $147.38K 10-Q · filed 2025-05-20 | |
| 2023-12-31 | $410.48K 10-K · filed 2026-05-04 | |
| 2022-12-31 | $6.17K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |